Dunn R T, Richards J B, Seiden L S
University of Chicago, Department of Pharmacological and Physiological Sciences, IL 60637.
Psychopharmacology (Berl). 1993;113(1):1-10. doi: 10.1007/BF02244325.
The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamol on a DRL 72-S schedule were dose-dependently antagonized by the beta antagonist metoprolol, but not changed by the 5HT antagonist methysergide. Additionally, neither salbutamol nor the antagonism of salbutamol by metoprolol caused disruption of DRL 72-S schedule performance. These results indicate that stimulation of beta receptors, and not of 5HT receptors, mediates salbutamol antidepressant-like effects on a DRL 72-S schedule.
β肾上腺素能(β)激动剂沙丁胺醇在低速率差异强化(DRL)72秒的实验安排中提高了强化率并降低了反应率。大多数临床使用的抗抑郁药也会导致DRL 72秒实验安排中的这些变化。β拮抗剂美托洛尔能剂量依赖性地拮抗沙丁胺醇对DRL 72秒实验安排的影响,但5-羟色胺拮抗剂麦角酰二乙胺则不会改变这种影响。此外,沙丁胺醇及其被美托洛尔拮抗的作用均未导致DRL 72秒实验安排的表现受到干扰。这些结果表明,对β受体而非5-羟色胺受体的刺激介导了沙丁胺醇在DRL 72秒实验安排中类似抗抑郁的作用。